-
1
-
-
77955635233
-
Cancer Statistics, 2010
-
Jemal, A.; Siegel, R.; Xu, J. Q.; Ward, E. Cancer Statistics, 2010 CA Cancer J. Clin. 2010, 60 (5) 277-300
-
(2010)
CA Cancer J. Clin.
, vol.60
, Issue.5
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.Q.3
Ward, E.4
-
2
-
-
0034768116
-
Detection of occult metastasis in patients with breast cancer
-
DOI 10.1002/ssu.1049
-
Hawes, D.; Neville, A. M.; Cote, R. J. Detection of occult metastasis in patients with breast cancer Semin. Surg. Oncol. 2001, 20 (4) 312-8 (Pubitemid 33044275)
-
(2001)
Seminars in Surgical Oncology
, vol.20
, Issue.4
, pp. 312-318
-
-
Hawes, D.1
Neville, A.M.2
Cote, R.J.3
-
3
-
-
9744274000
-
Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer
-
DOI 10.1158/1078-0432.CCR-04-1107
-
Mehta, K.; Fok, J.; Miller, F. R.; Koul, D.; Sahin, A. A. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer Clin. Cancer Res. 2004, 10 (23) 8068-76 (Pubitemid 39587548)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.23
, pp. 8068-8076
-
-
Mehta, K.1
Fok, J.2
Miller, F.R.3
Koul, D.4
Sahin, A.A.5
-
4
-
-
79957572444
-
Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells
-
Bachmeier, B.; Fichtner, I.; Killian, P. H.; Kronski, E.; Pfeffer, U.; Efferth, T. D. Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells PLoS One 2011, 6 (5) e20550
-
(2011)
PLoS One
, vol.6
, Issue.5
, pp. 20550
-
-
Bachmeier, B.1
Fichtner, I.2
Killian, P.H.3
Kronski, E.4
Pfeffer, U.5
Efferth, T.D.6
-
5
-
-
0026735778
-
Mechanisms of multidrug resistance in cancer treatment
-
Harris, A. L.; Hochhause, D. Mechanisms of multidrug resistance in cancer treatment Acta Oncol. 1992, 31 (2) 205-13
-
(1992)
Acta Oncol.
, vol.31
, Issue.2
, pp. 205-213
-
-
Harris, A.L.1
Hochhause, D.2
-
6
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan, D.; Weinberg, R. A. The hallmarks of cancer Cell 2000, 100 (1) 57-70 (Pubitemid 30046295)
-
(2000)
Cell
, vol.100
, Issue.1
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
7
-
-
3042687629
-
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
-
DOI 10.1073/pnas.0403317101
-
Laakkonen, P.; Akerman, M. E.; Biliran, H.; Yang, M.; Ferrer, F.; Karpanen, T.; Hoffman, R. M.; Ruoslahti, E. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (25) 9381-6 (Pubitemid 38812883)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.25
, pp. 9381-9386
-
-
Laakkonen, P.1
Akerman, M.E.2
Biliran, H.3
Yang, M.4
Ferrer, F.5
Karpanen, T.6
Hoffman, R.M.7
Ruoslahti, E.8
-
8
-
-
13844265843
-
Focus on lymphangiogenesis in tumor metastasis
-
DOI 10.1016/j.ccr.2005.01.017
-
Achen, M. G.; McColl, B. K.; Stacker, S. A. Focus on lymphangiogenesis in tumor metastasis Cancer Cell 2005, 7 (2) 121-7 (Pubitemid 40248338)
-
(2005)
Cancer Cell
, vol.7
, Issue.2
, pp. 121-127
-
-
Achen, M.G.1
McColl, B.K.2
Stacker, S.A.3
-
9
-
-
0034931882
-
Lymphangiogenesis and lymph node microdissemination
-
DOI 10.1006/gyno.2001.6292
-
Van Trappen, P. O.; Pepper, M. S. Lymphangiogenesis and lymph node microdissemination Gynecol. Oncol. 2001, 82 (1) 1-3 (Pubitemid 32634944)
-
(2001)
Gynecologic Oncology
, vol.82
, Issue.1
, pp. 1-3
-
-
Van Trappen, P.O.1
Pepper, M.S.2
-
10
-
-
0032923081
-
Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
-
DOI 10.1038/sj.bjc.6690356
-
Tsurusaki, T.; Kanda, S.; Sakai, H.; Kanetake, H.; Saito, Y.; Alitalo, K.; Koji, T. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis Br. J. Cancer 1999, 80 (1-2) 309-13 (Pubitemid 29210123)
-
(1999)
British Journal of Cancer
, vol.80
, Issue.1-2
, pp. 309-313
-
-
Tsurusaki, T.1
Kanda, S.2
Sakai, H.3
Kanetake, H.4
Saito, Y.5
Alitalo, K.6
Koji, T.7
-
11
-
-
0035126049
-
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
-
DOI 10.1038/84635
-
Stacker, S. A.; Caesar, C.; Baldwin, M. E.; Thornton, G. E.; Williams, R. A.; Prevo, R.; Jackson, D. G.; Nishikawa, S.; Kubo, H.; Achen, M. G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics Nat. Med. 2001, 7 (2) 186-91 (Pubitemid 32148485)
-
(2001)
Nature Medicine
, vol.7
, Issue.2
, pp. 186-191
-
-
Stacker, S.A.1
Caesar, C.2
Baldwin, M.E.3
Thornton, G.E.4
Williams, R.A.5
Prevo, R.6
Jackson, D.G.7
Nishikawa, S.-I.8
Kubo, H.9
Achen, M.G.10
-
12
-
-
71949100459
-
Artemisinin-transferrin conjugate retards growth of breast tumors in the rat
-
Lai, H.; Nakase, I.; Lacoste, E.; Singh, N. P.; Sasaki, T. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat Anticancer Res. 2009, 29 (10) 3807-10
-
(2009)
Anticancer Res.
, vol.29
, Issue.10
, pp. 3807-3810
-
-
Lai, H.1
Nakase, I.2
Lacoste, E.3
Singh, N.P.4
Sasaki, T.5
-
13
-
-
70449732094
-
Artemisinin-transferrin conjugate retards growth of breast tumors in the rat
-
Eastman, R. T.; Fidock, D. A. Artemisinin-transferrin conjugate retards growth of breast tumors in the rat Nat. Rev. Microbiol. 2009, 7 (10) 864-74
-
(2009)
Nat. Rev. Microbiol.
, vol.7
, Issue.10
, pp. 864-874
-
-
Eastman, R.T.1
Fidock, D.A.2
-
14
-
-
33646024956
-
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells
-
DOI 10.2174/138945006776359412
-
Efferth, T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells Curr. Drug Targets 2006, 7 (4) 407-21 (Pubitemid 43744832)
-
(2006)
Current Drug Targets
, vol.7
, Issue.4
, pp. 407-421
-
-
Efferth, T.1
-
15
-
-
40849097597
-
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation
-
DOI 10.1016/j.ijpharm.2007.09.003, PII S0378517307007569
-
Nakase, I.; Lai, H.; Singh, N. P.; Sasaki, T. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation Int. J. Pharm. 2008, 354 (1-2) 28-33 (Pubitemid 351400327)
-
(2008)
International Journal of Pharmaceutics
, vol.354
, Issue.1-2
, pp. 28-33
-
-
Nakase, I.1
Lai, H.2
Singh, N.P.3
Sasaki, T.4
-
16
-
-
80051887433
-
Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin
-
Efferth, T.; Herrmann, F.; Tahrani, A.; Wink, M. Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin Phytomedicine 2011, 18 (11) 959-69
-
(2011)
Phytomedicine
, vol.18
, Issue.11
, pp. 959-969
-
-
Efferth, T.1
Herrmann, F.2
Tahrani, A.3
Wink, M.4
-
17
-
-
84865958794
-
Effect of artemisin in on metastatic tumor growth and lymphangiogenesis in mice bearing Lewis lung carcinoma
-
Guo, Y.; Wang, J.; Zhang, B. C.; Chen, Z. T.; Gao, J. F.; Zhao, Y. J. Effect of artemisin in on metastatic tumor growth and lymphangiogenesis in mice bearing Lewis lung carcinoma J. Fourth Mil. Med. Univ. 2007, 28 (4) 357-60
-
(2007)
J. Fourth Mil. Med. Univ.
, vol.28
, Issue.4
, pp. 357-360
-
-
Guo, Y.1
Wang, J.2
Zhang, B.C.3
Chen, Z.T.4
Gao, J.F.5
Zhao, Y.J.6
-
18
-
-
84860677660
-
An injectable hybrid nanoparticle-in-oil-in-water submicron emulsion for improved delivery of poorly soluble drugs
-
doi: 10.1186/1556-276X-7-219
-
Wang, S.; Wang, H.; Liang, W.; Huang, Y. An injectable hybrid nanoparticle-in-oil-in-water submicron emulsion for improved delivery of poorly soluble drugs. Nanoscale Res. Lett. 2012, 7, doi: 10.1186/1556-276X-7-219.
-
(2012)
Nanoscale Res. Lett.
, vol.7
-
-
Wang, S.1
Wang, H.2
Liang, W.3
Huang, Y.4
-
19
-
-
36849067019
-
Nanocarriers as an emerging platform for cancer therapy
-
DOI 10.1038/nnano.2007.387, PII NNANO2007387
-
Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2007, 2 (12) 751-60 (Pubitemid 350223348)
-
(2007)
Nature Nanotechnology
, vol.2
, Issue.12
, pp. 751-760
-
-
Peer, D.1
Karp, J.M.2
Hong, S.3
Farokhzad, O.C.4
Margalit, R.5
Langer, R.6
-
20
-
-
0242584817
-
Micellar nanocontainers distribute to defined cytoplasmic organelles
-
DOI 10.1126/science.1078192
-
Savic, R.; Luo, L.; Eisenberg, A.; Maysinger, D. Micellar nanocontainers distribute to defined cytoplasmic organelles Science 2003, 300 (5619) 615-8 (Pubitemid 36520581)
-
(2003)
Science
, vol.300
, Issue.5619
, pp. 615-618
-
-
Savic, R.1
Luo, L.2
Eisenberg, A.3
Maysinger, D.4
-
21
-
-
29244477993
-
In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(ε-caprolactone) micelles
-
DOI 10.1016/j.jconrel.2005.10.008, PII S0168365905005365
-
Forrest, M. L.; Won, C. Y.; Malick, A. W.; Kwon, G. S. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(3- caprolactone) micelles J. Controlled Release 2006, 110 (2) 370-7 (Pubitemid 41827491)
-
(2006)
Journal of Controlled Release
, vol.110
, Issue.2
, pp. 370-377
-
-
Forrest, M.L.1
Won, C.-Y.2
Malick, A.W.3
Kwon, G.S.4
-
22
-
-
22544471541
-
Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone
-
DOI 10.1016/j.biomaterials.2005.03.045, PII S0142961205002929
-
Zhang, Y.; Zhuo, R. X. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly(ethylene glycol) and polycaprolactone Biomaterials 2005, 26 (33) 6736-42 (Pubitemid 41021767)
-
(2005)
Biomaterials
, vol.26
, Issue.33
, pp. 6736-6742
-
-
Zhang, Y.1
Zhuo, R.-X.2
-
23
-
-
34247642609
-
Targeted nanoparticles for cancer therapy
-
DOI 10.1016/S1748-0132(07)70083-X, PII S174801320770083X
-
Gu, F. X.; Karnik, R.; Wang, A. Z.; Alexis, F.; Levy-Nissenbaum, E.; Hong, S.; Langer, R. S; Farokhzad, O. C. Targeted nanoparticles for cancer therapy Nano Today 2007, 2 (3) 14-21 (Pubitemid 46672835)
-
(2007)
Nano Today
, vol.2
, Issue.3
, pp. 14-21
-
-
Gu, F.X.1
Karnik, R.2
Wang, A.Z.3
Alexis, F.4
Levy-Nissenbaum, E.5
Hong, S.6
Langer, R.S.7
Farokhzad, O.C.8
-
24
-
-
80055112766
-
The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles
-
Zhang, Y.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles Biomaterials 2012, 33 (2) 679-91
-
(2012)
Biomaterials
, vol.33
, Issue.2
, pp. 679-691
-
-
Zhang, Y.1
Zhang, H.2
Wang, X.3
Wang, J.4
Zhang, X.5
Zhang, Q.6
-
25
-
-
0036063778
-
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
-
DOI 10.1038/nm720
-
Laakkonen, P.; Porkka, K.; Hoffman, J. A; Ruoslahti, E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels Nat. Med. 2002, 8 (7) 751-5 (Pubitemid 34778730)
-
(2002)
Nature Medicine
, vol.8
, Issue.7
, pp. 751-755
-
-
Laakkonen, P.1
Porkka, K.2
Hoffman, J.A.3
Ruoslahti, E.4
-
26
-
-
52049123781
-
Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma
-
Fogal, V.; Zhang, L.; Krajewski, S.; Ruoslahti, E. Mitochondrial/cell- surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma Cancer Res. 2008, 68 (17) 7210-8
-
(2008)
Cancer Res.
, vol.68
, Issue.17
, pp. 7210-7218
-
-
Fogal, V.1
Zhang, L.2
Krajewski, S.3
Ruoslahti, E.4
-
27
-
-
59849110112
-
Targeting of albumin-embedded paclitaxel nanoparticles to tumors
-
Karmali, P. P.; Kotamraju, V. R.; Kastantin, M.; Black, M.; Missirlis, D.; Tirrell, M.; Ruoslahti, E. Targeting of albumin-embedded paclitaxel nanoparticles to tumors Nanomedicine 2009, 5 (1) 73-82
-
(2009)
Nanomedicine
, vol.5
, Issue.1
, pp. 73-82
-
-
Karmali, P.P.1
Kotamraju, V.R.2
Kastantin, M.3
Black, M.4
Missirlis, D.5
Tirrell, M.6
Ruoslahti, E.7
-
28
-
-
28544450961
-
Block copolymer micelles: Preparation, characterization and application in drug delivery
-
DOI 10.1016/j.jconrel.2005.09.034, PII S0168365905004906
-
Gaucher, G.; Dufresne, M. H.; Sant, V. P.; Kang, N.; Maysinger, D.; Leroux, J. C. Block copolymer micelles: preparation, characterization and application in drug delivery J. Controlled Release 2005, 109 (1-3) 169-88 (Pubitemid 41742123)
-
(2005)
Journal of Controlled Release
, vol.109
, Issue.1-3
, pp. 169-188
-
-
Gaucher, G.1
Dufresne, M.-H.2
Sant, V.P.3
Kang, N.4
Maysinger, D.5
Leroux, J.-C.6
-
29
-
-
84865964969
-
Studies on the assay of semi-synthetic derivatives by HPLC
-
Li, X. F.; Ci, D. Studies on the assay of semi-synthetic derivatives by HPLC J. Tibet Univ. 2009, 24 (1) 91-4
-
(2009)
J. Tibet Univ.
, vol.24
, Issue.1
, pp. 91-94
-
-
Li, X.F.1
Ci, D.2
-
30
-
-
33645013856
-
Lectin-conjugated PEG-PLA nanoparticles: Preparation and brain delivery after intranasal administration
-
Gao, X.; Tao, W.; Lu, W.; Zhang, Q.; Zhang, Y.; Jiang, X.; Fu, S. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration Biomaterials 2006, 27 (18) 3482-90
-
(2006)
Biomaterials
, vol.27
, Issue.18
, pp. 3482-3490
-
-
Gao, X.1
Tao, W.2
Lu, W.3
Zhang, Q.4
Zhang, Y.5
Jiang, X.6
Fu, S.7
-
31
-
-
79958231722
-
Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes
-
Xiang, Y.; Liang, L.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes J. Controlled Release 2011, 152 (3) 402-10
-
(2011)
J. Controlled Release
, vol.152
, Issue.3
, pp. 402-410
-
-
Xiang, Y.1
Liang, L.2
Wang, X.3
Wang, J.4
Zhang, X.5
Zhang, Q.6
-
32
-
-
81155137743
-
Regulation of cell proliferation by multi-layered phospholipid polymer hydrogel coatings through controlled release of paclitaxel
-
Choi, J.; Konno, T.; Takai, M.; Ishihara, K. Regulation of cell proliferation by multi-layered phospholipid polymer hydrogel coatings through controlled release of paclitaxel Biomaterials 2012, 33 (3) 954-61
-
(2012)
Biomaterials
, vol.33
, Issue.3
, pp. 954-961
-
-
Choi, J.1
Konno, T.2
Takai, M.3
Ishihara, K.4
-
33
-
-
34347230544
-
Sulforhodamine B colorimetric assay for cytotoxicity screening
-
Vichai, V.; Kirtikara, K. Sulforhodamine B colorimetric assay for cytotoxicity screening Nat. Protoc. 2006, 1 (3) 1112-6
-
(2006)
Nat. Protoc.
, vol.1
, Issue.3
, pp. 1112-1116
-
-
Vichai, V.1
Kirtikara, K.2
-
34
-
-
33846350486
-
Monitoring of tumor growth and metastasis potential in MDA-MB-435s/tk-luc human breast cancer xenografts
-
DOI 10.1016/j.nima.2006.10.051, PII S0168900206018481
-
Chang, Y. F.; Lin, Y. Y.; Wang, H. E.; Liu., R. S.; Pang, F.; Hwang, J. J. Monitoring of tumor growth and metastasis potential in MDA-MB-435s/tk-luc human breast cancer xenografts Nucl. Instrum. Methods Phys. Res., Sect. A 2007, 571 (1-2) 155-9 (Pubitemid 46136589)
-
(2007)
Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
, vol.571
, Issue.1-2 SPEC. ISS.
, pp. 155-159
-
-
Chang, Y.-F.1
Lin, Y.-Y.2
Wang, H.-E.3
Liu, R.-S.4
Pang, F.5
Hwang, J.-J.6
-
35
-
-
83555179075
-
Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma
-
Yu, Y.; Wang, Z. H.; Zhang, L.; Yao, H. J.; Zhang, Y.; Li, R. J.; Ju, R. J.; Wang, X. X.; Zhou, J.; Li, N.; Lu, W. L. Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma Biomaterials 2012, 33 (6) 1808-20
-
(2012)
Biomaterials
, vol.33
, Issue.6
, pp. 1808-1820
-
-
Yu, Y.1
Wang, Z.H.2
Zhang, L.3
Yao, H.J.4
Zhang, Y.5
Li, R.J.6
Ju, R.J.7
Wang, X.X.8
Zhou, J.9
Li, N.10
Lu, W.L.11
-
36
-
-
29244489232
-
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo
-
DOI 10.1158/0008-5472.CAN-05-1093
-
Mamot, C.; Drummond, D. C.; Noble, C. O.; Kallab, V.; Guo, Z.; Hong, K.; Kirpotin, D. B.; Park, J. W. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo Cancer Res. 2005, 65 (24) 11631-8 (Pubitemid 41821723)
-
(2005)
Cancer Research
, vol.65
, Issue.24
, pp. 11631-11638
-
-
Mamot, C.1
Drummond, D.C.2
Noble, C.O.3
Kallab, V.4
Guo, Z.5
Hong, K.6
Kirpotin, D.B.7
Park, J.W.8
-
37
-
-
83555165078
-
Preparation and characterization of chitosan-polyvinyl alcohol blend hydrogels for the controlled release of nano-insulin
-
Zu, Y.; Zhang, Y.; Zhao, X.; Shan, C.; Zu, S.; Wang, K.; Li, Y.; Ge, Y. Preparation and characterization of chitosan-polyvinyl alcohol blend hydrogels for the controlled release of nano-insulin Int. J. Biol. Macromol. 2012, 50 (1) 82-7
-
(2012)
Int. J. Biol. Macromol.
, vol.50
, Issue.1
, pp. 82-87
-
-
Zu, Y.1
Zhang, Y.2
Zhao, X.3
Shan, C.4
Zu, S.5
Wang, K.6
Li, Y.7
Ge, Y.8
-
38
-
-
0031440794
-
Molecular mechanisms of endocytosis
-
DOI 10.1016/S0092-8674(00)80461-4
-
Riezman, H.; Woodman, P. G.; van Meer, G.; Marsh, M. Molecular mechanisms of endocytosis Cell 1997, 91 (6) 731-8 (Pubitemid 28007730)
-
(1997)
Cell
, vol.91
, Issue.6
, pp. 731-738
-
-
Riezman, H.1
Woodman, P.G.2
Van Meer, G.3
Marsh, M.4
-
39
-
-
33750715718
-
Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer
-
Allen, T. M.; Cheng, W. W.; Hare, J. I.; Laginha, K. M. Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer Anticancer Agents Med. Chem. 2006, 6 (6) 513-23 (Pubitemid 44697110)
-
(2006)
Anti-Cancer Agents in Medicinal Chemistry
, vol.6
, Issue.6
, pp. 513-523
-
-
Allen, T.M.1
Cheng, W.W.K.2
Hare, J.I.3
Laginha, K.M.4
-
40
-
-
68949204885
-
NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells
-
Wang, X.; Wang, Y.; Chen, X.; Wang, J.; Zhang, X.; Zhang, Q. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells J. Controlled Release 2009, 139 (1) 56-62
-
(2009)
J. Controlled Release
, vol.139
, Issue.1
, pp. 56-62
-
-
Wang, X.1
Wang, Y.2
Chen, X.3
Wang, J.4
Zhang, X.5
Zhang, Q.6
-
41
-
-
79953053224
-
Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
-
Maruyama, K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects Adv. Drug Delivery Rev. 2011, 63 (3) 161-9
-
(2011)
Adv. Drug Delivery Rev.
, vol.63
, Issue.3
, pp. 161-169
-
-
Maruyama, K.1
-
42
-
-
80052061132
-
A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model
-
Wang, X.; Li, J.; Wang, Y.; Koenig, L.; Gjyrezi, A.; Giannakakou, P.; Shin, E. H.; Tighiouart, M.; Chen, Z. G.; Nie, S.; Shin, D. M. A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model ACS Nano 2011, 5 (8) 6184-94
-
(2011)
ACS Nano
, vol.5
, Issue.8
, pp. 6184-6194
-
-
Wang, X.1
Li, J.2
Wang, Y.3
Koenig, L.4
Gjyrezi, A.5
Giannakakou, P.6
Shin, E.H.7
Tighiouart, M.8
Chen, Z.G.9
Nie, S.10
Shin, D.M.11
-
43
-
-
0026603586
-
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
-
Gabizon, A. A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes Cancer Res. 1992, 52 (4) 891-6
-
(1992)
Cancer Res.
, vol.52
, Issue.4
, pp. 891-896
-
-
Gabizon, A.A.1
-
44
-
-
77953257877
-
Passive and active drug targeting: Drug delivery to tumors as an example
-
Torchilin, V. P. Passive and active drug targeting: drug delivery to tumors as an example Handb. Exp. Pharmacol. 2009, 197 (1) 3-53
-
(2009)
Handb. Exp. Pharmacol.
, vol.197
, Issue.1
, pp. 3-53
-
-
Torchilin, V.P.1
|